• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Drug-eluting or bare-metal stents in ST-elevation myocardial infarction: a growing dilemma or closer to an answer?

作者信息

Glaser Ruchira

机构信息

Christiana Care Center for Heart & Vascular Health, Newark, DE 19718, USA.

出版信息

J Invasive Cardiol. 2011 Aug;23(8):334-5.

PMID:21828396
Abstract
摘要

相似文献

1
Drug-eluting or bare-metal stents in ST-elevation myocardial infarction: a growing dilemma or closer to an answer?ST段抬高型心肌梗死中药物洗脱支架或裸金属支架：是日益棘手的困境还是更接近答案？
J Invasive Cardiol. 2011 Aug;23(8):334-5.
2
Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: an analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology hospital) and T-SEARCH (taxus stent evaluated at Rotterdam cardiology hospital) registries.雷帕霉素洗脱支架和紫杉醇洗脱支架与裸金属支架治疗ST段抬高型心肌梗死患者的六年临床结局比较：RESEARCH（鹿特丹心脏病医院评估的雷帕霉素洗脱支架）和T-SEARCH（鹿特丹心脏病医院评估的紫杉醇洗脱支架）注册研究分析
J Invasive Cardiol. 2011 Aug;23(8):336-41.
3
Long-Term outcome of drug-eluting stents compared with bare metal stents in ST-segment elevation myocardial infarction: results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in Primary Angioplasty (PASEO) Randomized Trial.药物洗脱支架与裸金属支架治疗ST段抬高型心肌梗死的长期疗效比较：紫杉醇或西罗莫司洗脱支架与裸金属支架在直接经皮冠状动脉介入治疗（PASEO）随机试验中的结果
Circulation. 2009 Sep 15;120(11):964-72. doi: 10.1161/CIRCULATIONAHA.108.830372. Epub 2009 Aug 31.
4
5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial.急性 ST 段抬高型心肌梗死患者行紫杉醇洗脱支架与金属裸支架初次经皮冠状动脉介入治疗 5 年随访：PASSION（紫杉醇洗脱支架与心肌梗死 ST 段抬高患者常规支架比较）试验的随访研究。
JACC Cardiovasc Interv. 2011 Jan;4(1):24-9. doi: 10.1016/j.jcin.2010.11.003.
5
Outcomes of patients treated with triple antithrombotic therapy after primary percutaneous coronary intervention for ST-elevation myocardial infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial).经皮冠状动脉介入治疗 ST 段抬高型心肌梗死患者三联抗栓治疗的结果（来自急性心肌梗死血管重建和支架置入与优化药物治疗的随机临床试验[HORIZONS-AMI]）。
Am J Cardiol. 2012 Mar 15;109(6):831-8. doi: 10.1016/j.amjcard.2011.10.046. Epub 2011 Dec 22.
6
Benefits of drug-eluting stents as compared to bare metal stent in ST-segment elevation myocardial infarction: four year results of the PaclitAxel or Sirolimus-Eluting stent vs bare metal stent in primary angiOplasty (PASEO) randomized trial.药物洗脱支架与裸金属支架相比在ST段抬高型心肌梗死中的获益：紫杉醇或西罗莫司洗脱支架与裸金属支架在直接血管成形术（PASEO）随机试验中的四年结果
Am Heart J. 2009 Oct;158(4):e43-50. doi: 10.1016/j.ahj.2009.03.016.
7
Primary percutaneous coronary intervention by drug-eluting balloon angioplasty: the nonrandomized fourth arm of the DEB-AMI (drug-eluting balloon in ST-segment elevation myocardial infarction) trial.药物洗脱球囊血管成形术进行的直接经皮冠状动脉介入治疗：DEB-AMI（ST段抬高型心肌梗死中的药物洗脱球囊）试验的非随机第四组。
Catheter Cardiovasc Interv. 2015 Oct;86 Suppl 1:S34-44. doi: 10.1002/ccd.26060. Epub 2015 Jun 29.
8
Long-term benefit using DES in STEMI patients.在ST段抬高型心肌梗死（STEMI）患者中使用药物洗脱支架（DES）的长期获益。
J Invasive Cardiol. 2011 Aug;23(8):342.
9
Sex-related Impact on Clinical Outcome of Everolimus-eluting Versus Bare-metal Stents in ST-segment Myocardial Infarction. Insights From the EXAMINATION Trial.依维莫司洗脱支架与裸金属支架在ST段抬高型心肌梗死中对临床结局的性别相关影响。来自EXAMINATION试验的见解
Rev Esp Cardiol (Engl Ed). 2015 May;68(5):382-9. doi: 10.1016/j.rec.2014.09.001. Epub 2014 Oct 29.
10
Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.尽管在急性心肌梗死中成功进行了机械干预，但导丝插入后持续无复流是一个早期且易于获得的死亡风险因素：来自 STRATEGY（单次大剂量替罗非班和西罗莫司洗脱支架与阿昔单抗和裸金属支架治疗急性心肌梗死）和 MULTISTRATEGY（多中心评估单次大剂量替罗非班与阿昔单抗与西罗莫司洗脱支架或裸金属支架治疗急性心肌梗死的研究）试验的汇总分析。
JACC Cardiovasc Interv. 2011 Jan;4(1):51-62. doi: 10.1016/j.jcin.2010.09.016.